These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 18376143

  • 21. p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.
    Dutto I, Sukhanova M, Tillhon M, Cazzalini O, Stivala LA, Scovassi AI, Lavrik O, Prosperi E.
    PLoS One; 2016; 11(1):e0146031. PubMed ID: 26730949
    [Abstract] [Full Text] [Related]

  • 22. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
    Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R.
    Cancer Res; 1998 Nov 15; 58(22):5075-8. PubMed ID: 9823314
    [Abstract] [Full Text] [Related]

  • 23. AMPK mediates a pro-survival autophagy downstream of PARP-1 activation in response to DNA alkylating agents.
    Zhou J, Ng S, Huang Q, Wu YT, Li Z, Yao SQ, Shen HM.
    FEBS Lett; 2013 Jan 16; 587(2):170-7. PubMed ID: 23201261
    [Abstract] [Full Text] [Related]

  • 24. Role of PARP-1 and PARP-2 in the expression of apoptosis-regulating genes in HeLa cells.
    Cohausz O, Althaus FR.
    Cell Biol Toxicol; 2009 Aug 16; 25(4):379-91. PubMed ID: 18587655
    [Abstract] [Full Text] [Related]

  • 25. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
    Muñoz-Gámez JA, López Viota J, Barrientos A, Carazo Á, Sanjuán-Nuñez L, Quiles-Perez R, Muñoz-de-Rueda P, Delgado Á, Ruiz-Extremera Á, Salmerón J.
    Liver Int; 2015 Apr 16; 35(4):1430-41. PubMed ID: 24821649
    [Abstract] [Full Text] [Related]

  • 26. Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis.
    Boulares AH, Zoltoski AJ, Yakovlev A, Xu M, Smulson ME.
    J Biol Chem; 2001 Oct 12; 276(41):38185-92. PubMed ID: 11461900
    [Abstract] [Full Text] [Related]

  • 27. Histone H2AX is a critical factor for cellular protection against DNA alkylating agents.
    Meador JA, Zhao M, Su Y, Narayan G, Geard CR, Balajee AS.
    Oncogene; 2008 Sep 25; 27(43):5662-71. PubMed ID: 18542054
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W, Alano CC, Garnier P, Swanson RA.
    J Neurosci Res; 2008 Sep 25; 79(1-2):216-23. PubMed ID: 15562437
    [Abstract] [Full Text] [Related]

  • 31. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A, Heilbronn R, zur Hausen H.
    Cancer Res; 1990 Sep 15; 50(18):5756-60. PubMed ID: 2118419
    [Abstract] [Full Text] [Related]

  • 32. Induction of the mitochondrial permeability transition by the DNA alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine. Sorting cause and consequence of mitochondrial dysfunction.
    Dodoni G, Canton M, Petronilli V, Bernardi P, Di Lisa F.
    Biochim Biophys Acta; 2004 Jul 23; 1658(1-2):58-63. PubMed ID: 15282175
    [Abstract] [Full Text] [Related]

  • 33. NAD(+) consumption in carcinogen-treated hamster cells overexpressing a dominant negative mutant of poly(ADP-ribose) polymerase.
    Küpper JH, Müller M, Wolf I.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):525-9. PubMed ID: 10558902
    [Abstract] [Full Text] [Related]

  • 34. p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.
    Cazzalini O, Donà F, Savio M, Tillhon M, Maccario C, Perucca P, Stivala LA, Scovassi AI, Prosperi E.
    DNA Repair (Amst); 2010 Jun 04; 9(6):627-35. PubMed ID: 20303835
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes.
    Ying W, Chen Y, Alano CC, Swanson RA.
    J Cereb Blood Flow Metab; 2002 Jul 04; 22(7):774-9. PubMed ID: 12142562
    [Abstract] [Full Text] [Related]

  • 38. Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment.
    Cieslik M, Pyszko J, Strosznajder JB.
    Neurochem Int; 2013 Apr 04; 62(5):626-36. PubMed ID: 23439385
    [Abstract] [Full Text] [Related]

  • 39. Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca(2+) Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
    Gerace E, Pellegrini-Giampietro DE, Moroni F, Mannaioni G.
    CNS Neurol Disord Drug Targets; 2015 Apr 04; 14(5):636-46. PubMed ID: 25924998
    [Abstract] [Full Text] [Related]

  • 40. Functional overexpression of human poly(ADP-ribose) polymerase in transfected rat tumor cells.
    Bernges F, Bürkle A, Küpper JH, Zeller WJ.
    Carcinogenesis; 1997 Apr 04; 18(4):663-8. PubMed ID: 9111197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.